Abstract

Background: Vitiligo is a skin pigmentation disorder characterised by areas of depigmentation, leaving patients with white patches. Aim: This aim of this study is to characterize clinical outcomes and assessed the quality of life related to women patients with vitiligo. Patients and methods During the study period, which began on 12 March 2022 and lasted until 26 September 2023, eighty female patients with vitiligo were recruited from the different hospitals in Iraq dermatology outpatient clinics. We also used the DLQI scale to measure the impact of skin conditions on patients’ lives and the Beck scale to measure depression levels. Results The study analyzed the demographic and clinical data of women patients with vitiligo, a skin condition affecting the skin and hair. The highest prevalence was found in women aged 25-30 years, with 50% of cases. The most common symptoms included depigmented skin, premature graying of hair, loss of color in mucous membranes, changes in retina color, and social and psychological impact. The affected body parts included the head and face in 60% of cases, hands and feet in 44 cases, and the entire body in 40 cases. The disease duration varied, with 5% having a duration of less than one year, 16% between two and four years, 12% between four and eight years, and 8% between eight and twelve years. The study also identified different patterns of progression in the disease, with patients demonstrating improvement in 7.8 ± 8.4, those with no change in disease status, those with slow progression, and those with rapid progression. Conclusion Our study showed that vitiligo had a negative impact on female patients in terms of physical and psychological aspects, which reduced their quality of life